Overview

A Study to Evaluate the Effects of Renal Function on Pharmacokinetics and Safety of DA-8010

Status:
Not yet recruiting
Trial end date:
2024-03-01
Target enrollment:
Participant gender:
Summary
This Study will evaluate the effects of renal function on pharmacokinetics and safety of DA-8010
Phase:
Phase 1
Details
Lead Sponsor:
Dong-A ST Co., Ltd.
Treatments:
DA-8010